Sana Biotechnology(SANA)
$1.880.00 (0.00%)
SANA
Sana Biotechnology ownership
$1.88
At close:0.00 (0.00%)
Want to see SANA full AI Analyst Report?
Sana Biotechnology (SANA) Ownership - Who Owns Sana Biotechnology?
904 Followers
Sana Biotechnology (SANA) Ownership Overview
- 13.62% Insiders
- 11.50% Mutual Funds
- 39.48% Other Institutional Investors
- 9.16% ETFs
- 26.23% Public Companies and Individual Investors
The ownership structure of Sana Biotechnology (SANA) stock is a mix of institutional, retail, and individual investors. Approximately 60.15% of the company’s stock is owned by Institutional Investors, 13.62% is owned by Insiders, and 26.23% is owned by Public Companies and Individual Investors.
Institutional holdings as of
The ownership structure of Sana Biotechnology (SANA) stock is a mix of institutional, retail, and individual investors. Approximately 60.15% of the company’s stock is owned by Institutional Investors, 13.62% is owned by Insiders, and 26.23% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2026 | Gilder Gagnon Howe & Co Llc. | $268,419 | |
| Sep 30, 2026 | Woodline Partners Lp | $3,842,713 | |
| Sep 30, 2026 | $47,760,042 | ||
| Sep 30, 2026 | Moore Capital Management Lp | $2,174,969 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Noubar Afeyan | 25,001,856 | Institution | 8.34% | 47,003,489 |
| Robert Nelsen | 22,761,125 | Insider | 7.60% | 42,790,915 |
| Peter Kolchinsky | 18,750,000 | Institution | 6.26% | 35,250,000 |
| Fidelity Mt. Vernon Street Trust | 16,472,376 | Institution | 5.50% | 30,968,067 |
| BlackRock, Inc. | 16,384,234 | Institution | 5.47% | 30,802,360 |
| Ishares | 9,216,719 | Institution | 3.08% | 17,327,432 |
| Steve Harr | 8,960,751 | Insider | 2.99% | 16,846,212 |
| Vanguard | 8,869,855 | Institution | 2.96% | 16,675,327 |
| Vanguard Index Funds | 8,172,419 | Institution | 2.73% | 15,364,148 |
| Spdr | 6,421,438 | Institution | 2.14% | 12,072,303 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Fidelity Mt. Vernon Street Trust | 16,472,376 | Institution | 5.50% | 30,968,067 |
| Vanguard Index Funds | 8,172,419 | Institution | 2.73% | 15,364,148 |
| Fidelity Salem Street Trust | 2,206,956 | Institution | 0.74% | 4,149,077 |
| Fidelity Concord Street Trust | 1,644,717 | Institution | 0.55% | 3,092,068 |
| Vanguard Scottsdale Funds | 1,268,732 | Institution | 0.42% | 2,385,216 |
| Fidelity Select Portfolios | 1,263,152 | Institution | 0.42% | 2,374,726 |
| Tiaa-cref Funds | 770,891 | Institution | 0.26% | 1,449,275 |
| Vanguard World Fund | 528,308 | Institution | 0.18% | 993,219 |
| Schwab Capital Trust | 516,446 | Institution | 0.17% | 970,918 |
| Goldman Sachs Trust | 339,015 | Institution | 0.11% | 637,348 |
Top ETF Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| SPDR S&P BIOTECH ETF, XBI ETF | 5,636,354 | Institution | 1.88% | 10,596,346 |
| Vanguard Total Stock Market ETF, VTI ETF | 4,926,516 | Institution | 1.64% | 12,661,146 |
| iShares Russell 2000 ETF, IWM ETF | 4,456,747 | Institution | 1.49% | 8,378,684 |
| Vanguard Extended Market ETF, VXF ETF | 2,200,466 | Institution | 0.73% | 5,655,198 |
| iShares Russell 2000 Growth ETF, IWO ETF | 1,616,670 | Institution | 0.54% | 3,039,340 |
| iShares Biotechnology ETF, IBB ETF | 1,441,490 | Institution | 0.48% | 2,710,001 |
| Vanguard Russell 2000 ETF, VTWO ETF | 1,008,160 | Institution | 0.34% | 2,590,971 |
| Schwab U.S. Small-Cap ETF, SCHA ETF | 1,003,835 | Institution | 0.34% | 1,887,210 |
| iShares MSCI USA Small-Cap Multifactor ETF, SMLF ETF | 611,128 | Institution | 0.20% | 1,148,921 |
| Vanguard Health Care ETF, VHT ETF | 530,982 | Institution | 0.18% | 1,364,624 |
FAQ
Who Owns Sana Biotechnology (SANA)?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 60.15% of the company's stock is held by institutional investors, 13.62% is held by insiders, and 26.23% is held by public companies and individual investors.
What percentage of Sana Biotechnology (SANA) stock is held by institutional investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 60.15% of Sana Biotechnology (SANA) stock is held by institutional investors: 11.50% by mutual funds, 9.16% by ETFs and 39.48% by other institutional investors.
What percentage of Sana Biotechnology (SANA) stock is held by retail investors?
According to the latest TipRanks data (13F holdings as of September 30, 2026), approximately 26.23% of Sana Biotechnology (SANA) stock is held by public companies and individual investors.
Who owns the most shares of Sana Biotechnology (SANA)?
Noubar Afeyan owns the most shares of Sana Biotechnology (SANA).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

